Ditto. I think those concerned with debt or no debt miss the message. As the revenues grow and margins expand, working capital will be available internally for market expansion. Further, Management knows what IMMD has and regional geographic expansion can most likely pursued through JV and licensing arrangements that may include upfront payment to IMMD. Accessing capital is not an issue. The primary issue is extending interest in the products. As shareholders we can help by using the products. I do not need the hair loss remedy, but I have been using the capsules for 10 years and have previously posted about my excellent results and those results of people I know. IMMD's beta glucan works NO DOUBT. Even my doc, who is of the archaic view has told me that my test results are outstanding and my "immune system is extraordinarily strong". That is the goal for promoting health.
News 
Market Data 
Discover 
AI
